Teicoplanin-resistant coagulase-negative staphylococcal bacteraemia in patients with haematological malignancies: a problem of increasing importance
Author(s) -
Livio Pagano
Publication year - 1997
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/40.5.738
Subject(s) - teicoplanin , coagulase , medicine , bacteremia , vancomycin , staphylococcal infections , microbiology and biotechnology , intensive care medicine , staphylococcus , staphylococcus aureus , antibiotics , biology , bacteria , genetics
The antibiotics were subsequently given by the oral route (co-trimoxazole at the same dosage and ciprofloxacin at 250 mg tds) and, after 2 weeks, the dosages were reduced (co-trimoxazole 480 mg bd and ciprofloxacin 250 mg bd). The patient completed a 4 week course of this regimen, during which time she remained afebrile. She was discharged and, at a 6 month follow-up assessment, was well and exhibited no signs of relapse. This case demonstrates that co-trimoxazole in combination with ciprofloxacin may be effective therapy in patients with IE caused by high-level gentamicin-resistant enterococci.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom